Showing results (181-190 of 333) with videos related to
Sort By:
Pageof 34
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 11, 2021
Gefitinib With Concurrent Thoracic Radiotherapy in Unresectable Locally Advanced NSCLC With EGFR Mutation; West Japan Oncology Group 6911LHiroaki Akamatsu, Haruyasu Murakami, Hideyuki Harada, et al.Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|August 30, 2008
Cigarette smoke condensate upregulates the gene and protein expression of proinflammatory cytokines in human fibroblast-like synoviocyte lineMiki Shizu, Yuka Itoh, Ryohei Sunahara, et al.European Journal of Pharmacology|April 13, 2024
Corosolic acid attenuates platelet-derived growth factor signaling in macrophages and smooth muscle cells of pulmonary arterial hypertensionAya Yamamura, Moe Fujiwara, Akiko Kawade, et al.International Journal of Oncology|December 16, 2014
Activated MET acts as a salvage signal after treatment with alectinib, a selective ALK inhibitor, in ALK-positive non-small cell lung cancerAkihiro Kogita, Yosuke Togashi, Hidetoshi Hayashi, et al.International Journal of Oncology|August 7, 2014
Hypoxia induces resistance to ALK inhibitors in the H3122 non-small cell lung cancer cell line with an ALK rearrangement via epithelial-mesenchymal transitionAkihiro Kogita, Yosuke Togashi, Hidetoshi Hayashi, et al.Anticancer Research|December 11, 2013
Phase I pharmacokinetic study of S-1 granules and nedaplatin for advanced head and neck cancerHidetoshi Hayashi, Isamu Okamoto, Shinya Ueda, et al.Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|February 12, 2008
[Drug-induced pulmonary damage due to inhalation of a waterproof spray]Hidetoshi Hayashi, Tomoya Ishii, Tadashi Ishida, et al.Clinical Lung Cancer|February 27, 2026
TIGOS Trial: A Randomized, Double-Blind, Phase III Trial of Atigotatug and Nivolumab Fixed-Dose Combination With Chemotherapy Versus Atezolizumab With Chemotherapy as First-Line Therapy in Patients With Extensive-Stage Small Cell Lung CancerLuis G Paz-Ares, Kenneth John O'Byrne, Melissa L Johnson, et al.Lung Cancer (Amsterdam, Netherlands)|May 3, 2011
Erlotinib after gefitinib failure in relapsed non-small cell lung cancer: clinical benefit with optimal patient selectionAkito Hata, Nobuyuki Katakami, Hiroshige Yoshioka, et al.Investigational New Drugs|March 21, 2017
Imaging and clinicopathological features of nivolumab-related cholangitis in patients with non-small cell lung cancerHisato Kawakami, Junko Tanizaki, Kaoru Tanaka, et al.Pageof 34